Artia Global Partners LP
48 holdingsFiling period: 2026-06-30Current AUM: $453.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax SA | 516.4K | $68.8M | $47.8M | 10.55% | -84,300 | 2026-06-30 |
| 2 | INSM | Insmed Inc | 589.1K | $62.8M | $56.4M | 12.43% | -319,360 | 2026-06-30 |
| 3 | TRVI | Trevi Therapeutics Inc | 2.21M | $41.2M | $28.4M | 6.26% | +197.3K | 2026-06-30 |
| 4 | BTSG | Brightspring Health Svcs Inc | 517.3K | $36.1M | $32.3M | 7.13% | +463.5K | 2026-06-30 |
| 5 | RVMD | Revolution Medicines Inc | 185.4K | $34.7M | $36.4M | 8.04% | +60.4K | 2026-06-30 |
| 6 | ARGX | Argenx SE | 29.7K | $27.6M | $25.9M | 5.71% | -- | 2026-06-30 |
| 7 | — | Alkermes PLC | 449.0K | $23.5M | $23.5M | 5.19% | -- | 2026-06-30 |
| 8 | TVTX | Travere Therapeutics Inc | 339.0K | $19.3M | $17.7M | 3.91% | +268.3K | 2026-06-30 |
| 9 | — | Astrazeneca PLC | 98.4K | $18.7M | $18.7M | 4.12% | +3.0K | 2026-06-30 |
| 10 | — | Newamsterdam Pharma Company | 503.9K | $17.1M | $17.1M | 3.77% | -- | 2026-06-30 |
| 11 | DNTH | Dianthus Therapeutics Inc | 163.0K | $15.9M | $12.8M | 2.83% | -- | 2026-06-30 |
| 12 | XBI | Spdr Series Trust | 100.0K | $15.8M | $15.3M | 3.38% | -- | 2026-06-30 |
| 13 | DGX | Quest Diagnostics Inc | 65.1K | $13.8M | $15.4M | 3.41% | +24.3K | 2026-06-30 |
| 14 | IONS | Ionis Pharmaceuticals Inc | 144.4K | $11.4M | $6.6M | 1.45% | -- | 2026-06-30 |
| 15 | EYPT | Eyepoint Inc | 767.1K | $11.0M | $311K | 0.07% | -- | 2026-06-30 |
| 16 | ALMS | Alumis Inc | 278.5K | $7.8M | $1.9M | 0.41% | -46,500 | 2026-06-30 |
| 17 | VKTX | Viking Therapeutics Inc | 180.7K | $7.0M | $4.8M | 1.07% | -- | 2026-06-30 |
| 18 | CELC | Celcuity Inc | 59.3K | $6.2M | $3.6M | 0.79% | +43.7K | 2026-06-30 |
| 19 | CYTK | Cytokinetics Inc | 70.7K | $6.0M | $4.5M | 1.00% | +54.4K | 2026-06-30 |
| 20 | MRK | Merck & Co Inc | 46.7K | $6.0M | $6.9M | 1.53% | -- | 2026-06-30 |
| 21 | RAPP | Rapport Therapeutics Inc | 138.5K | $5.8M | $4.1M | 0.90% | -- | 2026-06-30 |
| 22 | JNJ | Johnson & Johnson | 22.6K | $5.7M | $5.9M | 1.29% | -- | 2026-06-30 |
| 23 | GH | Guardant Health Inc | 38.1K | $5.7M | $6.2M | 1.37% | -- | 2026-06-30 |
| 24 | ABSI | Absci Corporation | 464.4K | $5.4M | $4.2M | 0.93% | -- | 2026-06-30 |
| 25 | SRRK | Scholar Rock Hldg Corp | 96.3K | $5.3M | $4.0M | 0.88% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2